ESMO scientific and educational resources on this topic
Recent medwireNews, books and resources from conferences are for ESMO Members only.
Tumour Sites: Central Nervous System Malignancies
Neuro-Oncology
Latest ESMO videos
Featured medwireNews
BRAF–MEK Inhibition May Offer ‘Notable Activity’ Against BRAF-Mutated Glioma
Adjuvant Temozolomide Benefit Confirmed For 1p/19q Non-Co-Deleted Anaplastic Glioma
Low Risk Of Intracranial Malignancy After Stereotactic Radiosurgery
HRQoL Data Add Support For TTFields In Glioblastoma Patients
E-Learning
ESMO E-Learning: Multidisciplinary Treatment of Glioblastoma
ESMO E-Learning: Management of Patients with Brain Metastases: Focusing on Radiotherapy
Factsheets on Biomarkers
TERT Mutations in Glioma: ESMO Biomarker Factsheet
MGMT Promoter Methylation in Glioma: ESMO Biomarker Factsheet
IDH1/2 Mutations in Glioma: ESMO Biomarker Factsheet
1p/19q Co-deletion in Glioma: ESMO Biomarker Factsheet
Meeting resources
When to incorporate surgery in the treatment of lung cancer brain metastases?
Presenter: Philippe Métellus
Session: Personalised treatment of lung cancer brain metastases
Resources:
Slides
Webcast
Challenges in the development of brain-penetrant kinase inhibitors
Presenter: Neeltje Steeghs
Session: Optimising kinase inhibitors
Resources:
Slides
Webcast
Invited Discussant of abstracts 26MO and 27MO
Presenter: Kapil Dhingra
Session: Mini Oral session
Resources:
Slides
Webcast
27MO - BDTX-1535, a CNS penetrant, irreversible inhibitor of intrinsic and acquired resistance EGFR mutations, demonstrates preclinical efficacy in NSCLC and GBM PDX models.
Presenter: Matthew Lucas
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
Participant Clinical Case Discussion: metastatic brain tumor
Presenter: M. Algar, ZA
Session: Session 3 - Development in Radiotherapy
Resources:
Slides